From: Oral versus intravenous sildenafil for pulmonary hypertension in neonates: a randomized trial
Oral sildenafil | IV sildenafil | P value | |
---|---|---|---|
Time (Hours) taken for pulmonary pressures to reduce below 25 mm Hg Median [IQR] | 48 (24—96) (N = 17) | 48 (36 – 60) (N = 15) | 0.302 |
Time for OI to decrease by 25% (hours) Median [IQR] | 12 (9–24) N = 9 | 24 (6–37.50) N = 14 | 0.281 |
Days on invasive ventilation Median [IQR] | 4 (2–7.5) N = 8a | 2.5 (2–3.75) N = 17b | 0.963 |
Days on non-invasive ventilation Median [IQR] | 5 (2–6.75) N = 20 | 6 (4.25–8.75) N = 20 | 0.831 |
Days on nasal oxygen Median [IQR] | 2.50 (0–6) N = 13 | 0 (0–3) N = 9 | 0.530 |
Duration of hospital stay (Days) Median [IQR] | 11.5 (8.75–21.50) N = 18 | 19 (12–25) N = 19 | 0.151 |
Outcome | > 0.99 | ||
Mortality | 0 | 0 | |
Discharge | 18 | 19 | |
Failure of treatment | 8 | 9 | > 0.99 |
Complications | 0.049 | ||
Hypotension | 0 | 4 | |
Poor cardiac contractility | 0 | 1 | |
Reached full feeds on (DOL) Median [IQR] | 5 (4–6.50) N = 13 | 4 (3–6.25) N = 18 | 0.361 |